Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.

2.50
Hdl Handle:
http://hdl.handle.net/10541/621019
Title:
Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.
Authors:
Frizziero, Melissa; Lamarca, Angela; Kordatou, Zoe; Barriuso, Jorge; Nuttall, Christina; McNamara, Mairéad G ( 0000-0002-2272-3678 ) ; Hubner, Richard A ( 0000-0002-7081-8823 ) ; Mansoor, Was; Manoharan, Prakash; Valle, Juan W ( 0000-0002-1999-0863 )
Affiliation:
The Christie NHS Foundation Trust, Manchester
Citation:
Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence. 2018, 106: 77-77 Neuroendocrinology
Journal:
Neuroendocrinology
Issue Date:
2018
URI:
http://hdl.handle.net/10541/621019
Type:
Meetings and Proceedings
Language:
en
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorFrizziero, Melissaen
dc.contributor.authorLamarca, Angelaen
dc.contributor.authorKordatou, Zoeen
dc.contributor.authorBarriuso, Jorgeen
dc.contributor.authorNuttall, Christinaen
dc.contributor.authorMcNamara, Mairéad Gen
dc.contributor.authorHubner, Richard Aen
dc.contributor.authorMansoor, Wasen
dc.contributor.authorManoharan, Prakashen
dc.contributor.authorValle, Juan Wen
dc.date.accessioned2018-05-15T20:18:45Z-
dc.date.available2018-05-15T20:18:45Z-
dc.date.issued2018-
dc.identifier.citationCarboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence. 2018, 106: 77-77 Neuroendocrinologyen
dc.identifier.urihttp://hdl.handle.net/10541/621019-
dc.language.isoenen
dc.titleCarboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalNeuroendocrinologyen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.